Fortaz
NDC 52565-109
Product Information
Fortaz is a NDA-approved product labeled by Teligent Pharma, Inc.. Ceftazidime is used to treat a wide variety of bacterial infections. It is supplied as a yellow product. This product entry covers the primary NDC 52565-109 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 52565-109?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CEFTAZIDIME (UNII: 9M416Z9QNR)
- CEFTAZIDIME ANHYDROUS (UNII: DZR1ENT301) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CARBONATE (UNII: 45P3261C7T)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 206422 - Fortaz 200 MG/ML Injectable Solution
- RxCUI: 206422 - ceftazidime 200 MG/ML Injectable Solution [Fortaz]
- RxCUI: 206422 - Fortaz 6 GM per 30 ML Injectable Solution
- RxCUI: 242800 - cefTAZidime 200 MG/ML Injectable Solution
- RxCUI: 242800 - ceftazidime 200 MG/ML Injectable Solution
* Please review the full disclaimer at the bottom of this page.